
FDA approves updated COVID vaccines for seniors and at‑risk adults
The FDA approved updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech to prevent severe disease from the dominant JN.1 lineage XFG subvariant, with approvals for adults 65+ and younger people with one or more chronic conditions; rollout is underway and insurers plan to cover the costs.







